Jyrki Mattila, Director at BIOSPECIFICS TECHNOLOGIES CORP (BSTC), sold 18,750 shares at $62.06 ($1.2M) on 2019-05-22, disclosed to the SEC on 2019-05-24.
Open-market sale of $1.2M BSTC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| AUXL | SELL | 2008-05-09 | $2.8M | — | Filing → |